Whistler Conference Centre Floorplan

Registered Attendees


Registered attendees (and speakers, organizers, etc.) will have access to the following items from their Account page:

  • Abstracts from speakers and poster sessions, including the joint meeting abstracts, available 30 days prior to the meeting (You can edit your own abstract from My Account page as well)

    NOTE: Abstract authors/submitters may choose to not have their abstract available online and in the secure mobile app until a week before the meeting.

  • Full participant list, including joint meeting participants
  • Printable Invoices and Invitation Letters
  • Scholarship Information
  • Lodging Information

Login to My Account page

Antibodies as Drugs: Translating Molecules into Treatments (C1)

Scientific Organizers: Paul W. H. I. Parren and Erica Ollmann Saphire


February 25—March 1, 2018

Whistler Conference Centre, Whistler, British Columbia, Canada


Sponsored by Bioverativ Therapeutics, ImmunoGen, Inc., OncoMed Pharmaceuticals, Inc., Pfizer Inc. and Regeneron Pharmaceuticals, Inc.


IT’S NOT TOO LATE TO SUBMIT YOUR ABSTRACT. Abstracts received can no longer be considered for oral short talks. Abstracts for poster display opportunities will be accepted until 6 weeks before meeting start date midnight MST.
BEWARE of booking lodging through companies unaffiliated with Keystone Symposia. Click here for more details.

Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies.

DEADLINES:
Scholarship Deadline: Oct 24, 2017 [details]
Discounted Abstract Deadline: Oct 24, 2017 [details]
Abstract Deadline: Nov 21, 2017 [details]
Discounted Registration Deadline: Dec 19, 2017 [details]


Click here to view Cancellation Policy

Submit an Abstract Register Yourself Deadlines and Fees

Rates and Deadlines listed below are for the 2018-C1 "Antibodies as Drugs: Translating Molecules into Treatments" conference only.

*All deadlines end at 11:59 PM US Mountain Standard Time

Deadline Date Cost
Discounted Abstract Deadline
More details
Before and On October 24, 2017 100.00 USD*
- 50.00 USD discount
Abstract Deadline
More details
After October 24, 2017 until January 14, 2018 100.00 USD*
* 50.00 USD of Abstract fee deducted from your registration fee when you register for this meeting
Scholarship
More details
October 24, 2017 n/a
Discounted NON-STUDENT Registration
More details
Before and On December 19, 2017 920.00 USD
(includes 200.00 discount)
Regular NON-STUDENT Registration
More details
After December 19, 2017 1120.00 USD
Discounted STUDENT Registration
More details
Before and On December 19, 2017 695.00 USD
(includes 200.00 discount)
Regular STUDENT Registration
More details
After December 19, 2017 895.00 USD

* Changes in payment type that result in a refund are subject to a processing fee.
* Currency exchange gains/losses are the responsibility of the registrant and the Keystone Symposia will accept no liability for money loss through bank charges, transfers or currency fluctuations.




Discounted Abstract Deadline: October 24, 2017


Abstract Submission Fee: 100.00 USD*
Submission by this date receives 50.00 USD discount.
*50.00 USD will be applied to Registration Fee when you register

Abstract Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadlines. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract early allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • accept your abstract online
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
(The Abstract Deadline: is November 21, 2017)

Global Health Travel Award Deadline:


Global Health Travel Award Details: You MUST complete your Global Health Travel Award appplication by the Global Health Travel Award Deadline and complete the other required steps (verify your contact information and submit a recommendation letter) to be considered for a travel award.


Click here to learn more about Global Health Travel Awards.

Scholarship Deadline: October 24, 2017


Scholarship Details: You MUST submit your abstract by the Scholarship Deadline and complete the other required steps (submit a scholarship application and submit a mentor letter) to be considered for a scholarship.

Click here to learn more about Scholarships.

Abstract Deadline: November 21, 2017


Abstract Submission Fee: 100.00 USD*
*50.00 USD will be applied to Registration Fee when you register

Details: It is best to submit your abstract early. Abstract and registration spaces are limited and may fill prior to the abstract or discounted registration deadline. Submitting an abstract does not constitute or guarantee registration.

Submitting your abstract by the Abstract Deadline allows us to:
  • submit your abstract to organizers to be considered for a short talk
  • include your abstract on our website and in our secure mobile app
  • reserve your space at the meeting for a poster presentation.**
**Submitting an abstract does not constitute or guarantee registration.
Abstracts submitted after the Abstract Deadline will NOT be considered for a short talk.

(Discounted Abstract Deadline: is October 24, 2017)

Discounted Registration Deadline: December 19, 2017


Registration Fee: 920.00 USD* (includes 200.00 USD discount)
Student Registration Fee: 695.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

After the Discounted Registration Deadline:


Registration Fee: 1120.00 USD*
Student Registration Fee: 895.00 USD* (must complete student verification form)

*Includes 50.00 USD of your abstract submission fee

Registration spaces are limited and may fill prior to discounted registration deadline.

Please be advised that a few meeting participants have received calls and emails from a number of different housing services - "Exhibitors Housing Services", "Global Housing", etc. THESE COMPANIES ARE NOT AFFILIATED WITH KEYSTONE SYMPOSIA and are not authorized by Keystone Symposia to contact you. These companies may tell you that the meeting is filling and seek to take your lodging reservation and obtain your credit card number. We highly recommend that you not make a reservation with these companies or any other housing service! These companies' representations to participants have been misleading. Please report to Keystone Symposia any calls or correspondence you might have received and book only through the lodging link on our website, an established travel agency, or directly with the hotel.
No registration fees are used to fund entertainment or alcohol at this conference

Conference Program    Print  |   View meeting in 12 hr (am/pm) time


The meeting will begin on Sunday, February 25 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Thursday, March 1 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Friday, March 2 in order to fully experience the meeting.

SUNDAY, FEBRUARY 25

16:00—20:00
Arrival and Registration

Grand Foyer
18:00—20:00
Welcome Mixer
No registration fees are used to fund alcohol served at this function.

Grand Foyer

MONDAY, FEBRUARY 26

07:00—08:00
Breakfast

Sea to Sky C
08:00—09:00
Welcome and Keynote Address
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Dennis R. Burton, The Scripps Research Institute, USA
Molecular Vaccine Design Guided by Human Anti-Viral Antibodies

09:00—11:15
Protective Antibody Responses
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
George Georgiou, University of Texas at Austin, USA
The Human Serological and BCR Antibody Repertoires in Cancer, Autoimmunity or Following Vaccination

Coffee Break

Erica Ollmann Saphire, The Scripps Research Institute, USA
Antibody-Mediated Protection Against Emerging Viral Threats

Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland
Protection by Non-Conventional Antibodies

Short Talk(s) Chosen from Abstracts

11:15—17:00
On Own for Lunch

11:15—13:00
Poster Setup

Grand Foyer
13:00—22:00
Poster Viewing

Grand Foyer
14:30—16:30
Workshop 1: Antibodies & Protection

Sea to Sky B
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
From Molecules to Vaccines
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Nancy L. Haigwood, Oregon Health & Science University, USA
Antibody-Based HIV Therapeutics: 'Hit Early, Hit Hard'

James E. Crowe, Jr., Vanderbilt University Medical Center, USA
Genetic and Structural Basis for Virus Neutralization by Human Antibodies

Robert F. Garry, Tulane University Health Sciences Center, USA
Antibody Treatment of Lassa Virus: From the Field to the Lab and Back

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky C
19:30—22:00
Poster Session 1

Grand Foyer

TUESDAY, FEBRUARY 27

07:00—08:00
Breakfast

Sea to Sky C
08:00—11:00
Antibodies as Biopharmaceuticals
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Janine Schuurman, Genmab B.V., Netherlands
Therapeutic Antibody Panorama: Highways, Scenic Routes and Dead-Ends

Karl Dane Wittrup, Massachusetts Institute of Technology, USA
Principles of Effective Antibody Therapeutics

Coffee Break

Marie H. Kosco-Vilbois, NovImmune SA, Switzerland
Creating Molecules that succeed in the Clinic

Emma M. Lees, Jounce Therapeutics, USA
JTX-2011: Mechanism of Action of an Agonist Antibody Targeting ICOS

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

13:00—22:00
Poster Viewing

Grand Foyer
16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
Antibody Fc-Mediated Mechanisms I
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Pamela J. Bjorkman, California Institute of Technology, USA
Structural Studies of Antibody and Receptor Binding to HIV-1 Env

Jan Terje Andersen, Oslo University Hospital, Norway
HERA: A Human Endothelial Cell-based Recycling Assay for Screening of FcRn Targeted Molecules

Jeffrey Steven Miller, University of Minnesota, USA
Strategies to Use Trispecific Killer Engagers to Make NK Cells Antigen Specific

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky C
19:30—22:00
Poster Session 2

Grand Foyer

WEDNESDAY, FEBRUARY 28

07:00—08:00
Breakfast

Sea to Sky C
08:00—11:00
Antibody Fc-Mediated Mechanisms II
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Paul W. H. I. Parren, Leiden University Medical Center, Netherlands
Complement Activation at the Molecular Level

Suzan Rooijakkers, UMC Utrecht, Netherlands
EMBO Young Investigator Lecture: Antibody-Mediated Killing of Bacteria by Complement

Coffee Break

Galit Alter, Ragon Institute of MGH, MIT and Harvard, USA
Correlate Guided Approaches to Develop Antibodies against Ebola Virus Infection

Richard S. Blumberg, Brigham and Women's Hospital, USA
Cross-Presentation and Immune Effects Mediated by Antibody

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

13:00—20:00
Poster Viewing

Grand Foyer
14:30—16:30
Workshop 2: Therapeutic Antibodies
- Structural aspects of antibodies, novel insights - Novel therapeutic antibody formats - Novel antibody technologies - From target to therapy - Newly approved and upcoming antibody therapeutics

Sea to Sky B
Short Talks Chosen from Abstracts

16:30—17:00
Coffee Available

Grand Foyer
17:00—19:00
Exploiting Effector Cell Responses
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Sergio A. Quezada, University College London, UK
Defining the Role of Fc Receptors and the Tumor Microenvironment in the Activity of Immune Modulatory Antibodies

Bertrand Routy, University of Toronto, Canada
The Gut Microbiota as a Novel Predictor of Immune Checkpoint Inhibitors Response?

Marjolein van Egmond, VU University Medical Center, Netherlands
Translating Antibody – Effector Cell Cross-Talk to Immunotherapy

Short Talk Chosen from Abstracts

19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky C

THURSDAY, MARCH 1

07:00—08:00
Breakfast

Sea to Sky C
08:00—11:00
Novel Ways to Deliver Antibody Therapy
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Ugur Sahin, TRON – Translationale Oncology, Germany
Antibody and mRNA-Based Therapeutics

Mark Cobbold, Massachusetts General Hospital, USA
Retargeting T Cells for Tumor Therapy

Coffee Break

Speaker to be Announced

Speaker to be Announced

Short Talk(s) Chosen from Abstracts

11:00—17:00
On Own for Lunch

16:30—17:00
Coffee Available

Grand Foyer
17:00—18:45
From Molecules to the Clinic
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
Ira Mellman, Genentech, Inc., USA
Antibodies in Cancer Immunotherapy

David E. Szymkowski, Xencor, USA
Exploring Novel Mechanisms of Action and Clinical Outcomes of Therapeutic Antibodies Fc-Engineered to Optimally Engage Fc Gamma RIIb

John M. Lambert, ImmunoGen, Inc., USA
Antibody-Drug Conjugates (ADCs): The Magic Bullet Revisited

18:45—19:00
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Registered attendees can view abstracts starting on 01/25/2018

Sea to Sky B
19:00—20:00
Social Hour with Lite Bites
No registration fees are used to fund alcohol served at this function.

Sea to Sky C
20:00—23:00
Entertainment
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Sea to Sky C

FRIDAY, MARCH 2

 
Departure


*Session Chair †Invited, not yet responded.



We gratefully acknowledge support for this conference from:


Directors' Fund


These generous unrestricted gifts allow our Directors to schedule meetings in a wide variety of important areas, many of which are in the early stages of research.

Click here to view all of the donors who support the Directors' Fund.



Keystone Symposia thanks our Sponsors for generously supporting this meeting:

Bioverativ Therapeutics ImmunoGen, Inc.
OncoMed Pharmaceuticals, Inc. Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
 

We gratefully acknowledge the generous grant for this conference provided by:


National Institutes of Health

Grant No. 1 R13 AI136247-01

Funding for this conference was made possible (in part) by 1 R13 AI136247-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.


We gratefully acknowledge additional support for this conference from:

Adipogen International
The Antibody Society


Zymeworks
 

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:



EMBO Young Investigator Programme


Genmab A/S


ImmunoGen, Inc.


We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:


Click here to view more of these organizations


Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:


Click here to view more of these organizations


If your organization is interested in joining these entities in support of Keystone Symposia, please contact: Sarah Lavicka, Director of Development, Email: sarahl@keystonesymposia.org,
Phone:+1 970-262-2690

Click here for more information on Industry Support and Recognition Opportunities.

If you are interested in becoming an advertising/marketing in-kind partner, please contact:
Yvonne Psaila, Director, Marketing and Communications, Email: yvonnep@keystonesymposia.org,
Phone:+1 970-262-2676